Benign vs. All Cancer
Modalities	Parameters	AUC	Sensitivity	Specificity
T2w, DWI	ADC, T2	0.93	100	83.3
T2w, DCE	T2, Slope	0.80	95.8	63.9
T2w, MRSI	Cho/Cre, T2	0.98	100	86.1
T2, DWI, DCE	ADC, T2	0.93	100	83.3
T2, DCE, MRSI	Cho/Cre, T2	0.98	100	86.1
T2, DWI, MRSI	Cho/Cre, ADC	0.99	100	91.7
All	Cho/Cre, ADC	0.99	100	91.7
≤G3+3 vs. ≥G3+4
Modalities	Parameters	AUC	Sensitivity	Specificity
T2w, DWI	ADC	0.74	73.3	72.2
T2w, DCE	WO, VL	0.80	93.3	61.1
T2w, MRSI	CCC, Cho/Cre, Cit	0.80	53.3	94.4
T2, DWI, DCE	WO, ADC, VL	0.89	86.7	83.3
T2, DCE, MRSI	WO, Cre	0.86	80.0	83.3
T2, DWI, MRSI	Cho/Cre, ADC, Cho/Cit, CCC	0.93	80.0	100
All	WO, ADC, Cre	0.93	86.7	94.4
≤G3+4 vs. ≥G4+3
Modalities	Parameters	AUC	Sensitivity	Specificity
T2w, DWI	ADC	0.62	55.6	81.8
T2w, DCE	Ktrans	0.71	77.8	68.2
T2w, MRSI	Cho	0.69	100	50
T2, DWI, DCE	Ktrans	0.71	77.8	68.2
T2, DCE, MRSI	Cho, WO	0.92	77.8	100
T2, DWI, MRSI	Cho	0.69	100	50
All	Cho, WO	0.92	77.8	100

PE = peak enhancement, Slope = maximal enhancement slope, WO = washout slope